Bellevue Group AG - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q1 2022$1,661,000
-39.2%
26,000
+2.0%
0.02%
-32.1%
Q4 2021$2,731,000
+68.8%
25,500
+26.2%
0.03%
+7.7%
Q4 2019$1,618,000
+39.4%
20,200
+27.8%
0.03%
+18.2%
Q3 2019$1,161,000
-20.6%
15,800
+1.9%
0.02%
-12.0%
Q2 2019$1,462,00015,5000.02%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2019
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 716,539$36,192,00012.35%
CADIAN CAPITAL MANAGEMENT, LP 2,020,629$102,062,0006.89%
Casdin Capital, LLC 1,150,000$58,087,0004.91%
DAFNA Capital Management LLC 261,280$13,197,0003.60%
Nextech Invest Ltd. 188,228$9,507,0003.21%
Eagle Health Investments LP 170,551$8,615,0002.01%
Boxer Capital, LLC 507,374$25,627,0001.62%
Rock Springs Capital Management LP 979,174$49,458,0001.44%
EFG Asset Management (North America) Corp. 130,454$6,589,0001.39%
Integral Health Asset Management, LLC 130,000$6,566,0001.35%
View complete list of BLUEPRINT MEDICINES CORP shareholders